Open AccessMetformin and Weight Loss in Obese Women with Polycystic Ovary Syndrome: Comparison of Doses
Author(s) -
L Harborne,
Naveed Sattar,
Jane E. Norman,
Richard Fleming
Publication year - 2005
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2004-2283
Subject(s) - metformin , polycystic ovary , medicine , weight loss , endocrinology , body mass index , obesity , lipid profile , insulin resistance , diabetes mellitus , insulin
Metformin treatment of women with polycystic ovary syndrome (PCOS) is widespread, as determined by studies with diverse patient populations. No comparative examination of weight changes or metabolite responses to different doses has been reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom